Adrenal and thyroid function in the fetus and preterm infant

Korean Journal of Pediatrics

Volumn 57, Issue 10, 2014, Pages 431-439

  Chung, Hye Rim ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Adrenal glands; Premature infant; Thyroid

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3 (OR 17) BETA HYDROXYSTEROID DEHYDROGENASE; 3, 3', 5' TRIIODOTHYRONINE; ADRENAL HORMONE; ADRENALIN; ALDOSTERONE; ALDOSTERONE SYNTHASE; CHORIONIC GONADOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; ESTRADIOL; ESTRONE; HYDROCORTISONE; HYDROXYPROGESTERONE; LEVOTHYROXINE; LIOTHYRONINE; NORADRENALIN; PRASTERONE; PRASTERONE SULFATE; PROTIRELIN; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE; STEROID HORMONE; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; CHILDBIRTH; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL HYPOTHYROIDISM; ENDOCRINE SYSTEM; FETUS MATURITY; GESTATIONAL AGE; HOMEOSTASIS AND REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; HYPOTHYROXINEMIA; METABOLITE; MOTHER FETUS RELATIONSHIP; PATHOPHYSIOLOGY; PERINATAL PERIOD; PREMATURITY; REVIEW; STRESS; THYROID DISEASE; THYROID FUNCTION; TISSUE DIFFERENTIATION; VASOPRESSOR RESISTANT HYPOTENSION;

EID: 84908096637     PISSN: 17381061     EISSN: 20927258     Source Type: Journal    
DOI: 10.3345/kjp.2014.57.10.431     Document Type: Review

References (91)

1. Mesiano S, Jaffe RB. Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997;18:378-403.
2. Fisher DA. Fetal thyroid function: diagnosis and management of fetal thyroid disorders. Clin Obstet Gynecol 1997;40:16-31.
3. Ng PC. The fetal and neonatal hypothalamic-pituitary-adrenal axis. Arch Dis Child Fetal Neonatal Ed 2000;82:F250-4.
4. Hillman NH, Kallapur SG, Jobe AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol 2012;39:769-83.
5. Watterberg KL. Adrenocortical function and dysfunction in the fetus and neonate. Semin Neonatol 2004;9:13-21.
6. La Gamma EF, van Wassenaer AG, Ares S, Golombek SG, Kok JH, Quero J, et al. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation. Pediatrics 2009;124:e258-68.
7. Heckmann M, Wudy SA, Haack D, Pohlandt F. Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed 1999;81:F171-4.
8. Heckmann M, Hartmann MF, Kampschulte B, Gack H, Bodeker RH, Gortner L, et al. Cortisol production rates in preterm infants in relation to growth and illness: a noninvasive prospective study using gas chromatography-mass spectrometry. J Clin Endocrinol Metab 2005;90:5737-42.
9. Ng PC. Is there a "normal" range of serum cortisol concentration for preterm infants? Pediatrics 2008;122:873-5.
10. Calixto C, Martinez FE, Jorge SM, Moreira AC, Martinelli CE Jr. Correlation between plasma and salivary cortisol levels in preterm infants. J Pediatr 2002;140:116-8.
11. Williams FL, Simpson J, Delahunty C, Ogston SA, Bongers- Schokking JJ, Murphy N, et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004;89:5314-20.
12. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR. Williams textbook of endocrinology. 11th ed. Philadelphia: Saunders, 2008.
13. Hanley NA, Rainey WE, Wilson DI, Ball SG, Parker KL. Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol Endocrinol 2001;15:57-68.
14. Ishimoto H, Jaffe RB. Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit. Endocr Rev 2011;32:317-55.
15. Pasqualini JR. Enzymes involved in the formation and transformation of steroid hormones in the fetal and placental compartments. J Steroid Biochem Mol Biol 2005;97:401-15.
16. Rainey WE, Rehman KS, Carr BR. Fetal and maternal adrenals in human pregnancy. Obstet Gynecol Clin North Am 2004;31:817-35.
17. Benediktsson R, Calder AA, Edwards CR, Seckl JR. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf) 1997;46:161-6.
18. Murphy BE, Clark SJ, Donald IR, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 1974;118:538-41.
19. Ballabio M, Nicolini U, Jowett T, Ruiz de Elvira MC, Ekins RP, Rodeck CH. Maturation of thyroid function in normal human foetuses. Clin Endocrinol (Oxf) 1989;31:565-71.
20. Contempre B, Jauniaux E, Calvo R, Jurkovic D, Campbell S, de Escobar GM. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab 1993;77:1719-22.
21. De Nayer P, Cornette C, Vanderschueren M, Eggermont E, Devlieger H, Jaeken J, et al. Serum thyroglobulin levels in preterm neonates. Clin Endocrinol (Oxf) 1984;21:149-53.
22. Sobrero G, Muñoz L, Bazzara L, Martin S, Silvano L, Iorkansky S, et al. Thyroglobulin reference values in a pediatric infant population. Thyroid 2007;17:1049-54.
23. Krassas GE, Rivkees SA, Kiess W. Diseases of the thyroid in childhood and adolescence. Basel: S Karger AG, 2007.
24. Thorpe-Beeston JG, Nicolaides KH, Felton CV, Butler J, McGregor AM. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 1991;324:532-6.
25. Kester MH, Martinez de Mena R, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 2004; 89:3117-28.
26. Sperling MA. Pediatric endocrinology. 3rd ed. Philadelphia: Saunders, 2008.
27. Polk DH, Reviczky A, Lam RW, Fisher DA. Thyrotropin-releasing hormone in ovine fetus: ontogeny and effect of thyroid hormone. Am J Physiol 1991;260(1 Pt 1):E53-8.
28. Liggins GC. The role of cortisol in preparing the fetus for birth. Reprod Fertil Dev 1994;6:141-50.
29. Bird JA, Spencer JA, Mould T, Symonds ME. Endocrine and metabolic adaptation following caesarean section or vaginal delivery. Arch Dis Child Fetal Neonatal Ed 1996;74:F132-4.
30. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996;97:210-5.
31. Watterberg KL, Scott SM, Naeye RL. Chorioamnionitis, cortisol, and acute lung disease in very low birth weight infants. Pediatrics 1997;99:E6.
32. Feingold SB, Brown RS. Neonatal thyroid function. NeoReviews 2010;11:e640-6.
33. Fisher DA, Nelson JC, Carlton EI, Wilcox RB. Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid 2000;10:229-34.
34. Honour JH, Wickramaratne K, Valman HB. Adrenal function in preterm infants. Biol Neonate 1992;61:214-21.
35. Bolt RJ, Van Weissenbruch MM, Popp-Snijders C, Sweep FG, Lafeber HN, Delemarre-van de Waal HA. Maturity of the adrenal cortex in very preterm infants is related to gestational age. Pediatr Res 2002;52:405-10.
36. Fernandez EF, Montman R, Watterberg KL. ACTH and cortisol response to critical illness in term and late preterm newborns. J Perinatol 2008;28:797-802.
37. Nykanen P, Heinonen K, Riepe FG, Sippell WG, Voutilainen R. Serum concentrations of adrenal steroids and their precursors as a measure of maturity of adrenocortical function in very premature newborns. Horm Res Paediatr 2010;74:358-64.
38. Masumoto K, Kusuda S, Aoyagi H, Tamura Y, Obonai T, Yamasaki C, et al. Comparison of serum cortisol concentrations in preterm infants with or without late-onset circulatory collapse due to adrenal insufficiency of prematurity. Pediatr Res 2008;63:686-90.
39. Colasurdo MA, Hanna CE, Gilhooly JT, Reynolds JW. Hydrocortisone replacement in extremely premature neonates with cortisol insufficiency [abstract]. Clin Res 1989;37:180A.
40. Ward RM, Kimura RE, Rich-Denson C. Addisonian crisis in extremely premature neonates [abstract]. Clin Res 1991;39:11A.
41. Ng PC, Lam CW, Fok TF, Lee CH, Ma KC, Chan IH, et al. Refractory hypotension in preterm infants with adrenocortical insufficiency. Arch Dis Child Fetal Neonatal Ed 2001;84:F122-4.
42. Ng PC, Lee CH, Lam CW, Ma KC, Fok TF, Chan IH, et al. Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2004;89:F119-26.
43. Fernandez E, Schrader R, Watterberg K. Prevalence of low cortisol values in term and near-term infants with vasopressor-resistant hypotension. J Perinatol 2005;25:114-8.
44. Langer M, Modi BP, Agus M. Adrenal insufficiency in the critically ill neonate and child. Curr Opin Pediatr 2006;18:448-53.
45. Sari FN, Dizdar EA, Oguz SS, Andiran N, Erdeve O, Uras N, et al. Baseline and stimulated cortisol levels in preterm infants: is there any clinical relevance? Horm Res Paediatr 2012;77:12-8.
46. Ng PC, Wong GW, Lam CW, Lee CH, Wong MY, Fok TF, et al. The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants. J Clin Endocrinol Metab 1997;82:797-9.
47. Matsukura T, Kawai M, Marumo C, Iwanaga K, Yoshida K, Shibata M, et al. Diagnostic value of salivary cortisol in the CRH stimulation test in premature infants. J Clin Endocrinol Metab 2012;97:890-6.
48. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-91.
49. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-88.
50. Nordenstrom A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17- hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics 2001;108:E68.
51. Huysman MW, Hokken-Koelega AC, De Ridder MA, Sauer PJ. Adrenal function in sick very preterm infants. Pediatr Res 2000; 48:629-33.
52. Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA. Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab 1994;78:266-70.
53. Krasowski MD, Drees D, Morris CS, Maakestad J, Blau JL, Ekins S. Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clin Pathol 2014;14:33.
54. Riepe FG, Mahler P, Sippell WG, Partsch CJ. Longitudinal study of plasma pregnenolone and 17-hydroxypregnenolone in full-term and preterm neonates at birth and during the early neonatal period. J Clin Endocrinol Metab 2002;87:4301-6.
55. Kari MA, Raivio KO, Stenman UH, Voutilainen R. Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy. Pediatr Res 1996;40:319-24.
56. Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, et al. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia. Pediatr Res 2004;56:701-5.
57. Chung HR, Shin CH, Yang SW, Yun KA, Lee YA, Park SE, et al. Interpretation of screening for congenital adrenal hyperplasia in preterm infants. Korean J Pediatr 2008;51:616-21.
58. Uhrmann S, Marks KH, Maisels MJ, Friedman Z, Murray F, Kulin HE, et al. Thyroid function in the preterm infant: a longitudinal assessment. J Pediatr 1978;92:968-73.
59. Mandel SJ, Hermos RJ, Larson CA, Prigozhin AB, Rojas DA, Mitchell ML. Atypical hypothyroidism and the very low birthweight infant. Thyroid 2000;10:693-5.
60. van Wassenaer AG, Kok JH. Hypothyroxinaemia and thyroid function after preterm birth. Semin Neonatol 2004;9:3-11.
61. Frank JE, Faix JE, Hermos RJ, Mullaney DM, Rojan DA, Mitchell ML, et al. Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening. J Pediatr 1996;128:548- 54.
62. Savin S, Cvejie D, Nedic O, Radosavljevic R. Thyroid hormone synthesis and storage in the thyroid gland of human neonates. J Pediatr Endocrinol Metab 2003;16:521-8.
63. Chung HR, Shin CH, Yang SW, Choi CW, Kim BI, Kim EK, et al. High incidence of thyroid dysfunction in preterm infants. J Korean Med Sci 2009;24:627-31.
64. Scratch SE, Hunt RW, Thompson DK, Ahmadzai ZM, Doyle LW, Inder TE, et al. Free thyroxine levels after very preterm birth and neurodevelopmental outcomes at age 7 years. Pediatrics 2014; 133:e955-63.
65. Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2007;(1):CD005948.
66. Delange F. Optimal iodine nutrition during pregnancy, lactation and the neonatal period. Int J Endocrinol Metab 2004;2:1-12.
67. Ares S, Escobar-Morreale HF, Quero J, Duran S, Presas MJ, Herruzo R, et al. Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab 1997;82:1704-12.
68. Ibrahim M, de Escobar GM, Visser TJ, Duran S, van Toor H, Strachan J, et al. Iodine deficiency associated with parenteral nutrition in extreme preterm infants. Arch Dis Child Fetal Neonatal Ed 2003;88:F56-7.
69. van Wassenaer AG, Stulp MR, Valianpour F, Tamminga P, Ris Stalpers C, de Randamie JS, et al. The quantity of thyroid hormone in human milk is too low to influence plasma thyroid hormone levels in the very preterm infant. Clin Endocrinol (Oxf) 2002;56: 621-7.
70. Chung HR, Shin CH, Yang SW, Choi CW, Kim BI. Subclinical hypothyroidism in Korean preterm infants associated with high levels of iodine in breast milk. J Clin Endocrinol Metab 2009;94: 4444-7.
71. Larson C, Hermos R, Delaney A, Daley D, Mitchell M. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003;143:587-91.
72. De La Vieja A, Dohan O, Levy O, Carrasco N. Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 2000;80:1083-105.
73. Aitken J, Williams FL. A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine. Arch Dis Child Fetal Neonatal Ed 2014;99:F21-8.
74. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-90.
75. Leger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab 2014;99:363-84.
76. Leger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm Res Paediatr 2014;81:80-103.
77. Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr 2011;158:538-42.
78. Seri I, Tan R, Evans J. Cardiovascular effects of hydrocortisone in preterm infants with pressor-resistant hypotension. Pediatrics 2001;107:1070-4.
79. Noori S, Siassi B, Durand M, Acherman R, Sardesai S, Ramanathan R. Cardiovascular effects of low-dose dexamethasone in very low birth weight neonates with refractory hypotension. Biol Neonate 2006;89:82-7.
80. Ng PC, Lee CH, Bnur FL, Chan IH, Lee AW, Wong E, et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics 2006;117:367-75.
81. Choi EJ, Sohn JA, Lee EH, Lee JY, Lee HJ, Chung HR, et al. Clinical picture of adrenal insufficiency-associated hypotension in preterm infants. J Korean Soc Neonatol 2011;18:82-8.
82. Lee JA, Choi CW, Kim EK, Kim HS, Kim BI, Choi JH. Late-onset hypotension and late circulatory collapse due to adrenal insufficiency in preterm infants with gestational age less than 32 weeks. J Korean Soc Neonatol 2011;18:211-20.
83. Lee WJ, Kim MY, Cho HJ, Lee JS, Son DW. Clinical features of late-onset circulatory collapse in preterm infants. Korean J Perinatol 2013;24:148-57.
84. Chowdhry P, Scanlon JW, Auerbach R, Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984;73:301-5.
85. Amato M, Pasquier S, Carasso A, Von Muralt G. Postnatal thyroxine administration for idiopathic respiratory distress syndrome in preterm infants. Horm Res 1988;29:27-30.
86. Smith LM, Leake RD, Berman N, Villanueva S, Brasel JA. Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. J Perinatol 2000;20: 427-31.
87. Biswas S, Buffery J, Enoch H, Bland M, Markiewicz M, Walters D. Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks gestation: results of the THORN trial: thyroid hormone replacement in neonates. Pediatr Res 2003;53:48-56.
88. van Wassenaer AG, Kok JH, de Vijlder JJ, Briet JM, Smit BJ, Tamminga P, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997;336:21-6.
89. van Wassenaer AG, Briet JM, van Baar A, Smit BJ, Tamminga P, de Vijlder JJ, et al. Free thyroxine levels during the first weeks of life and neurodevelopmental outcome until the age of 5 years in very preterm infants. Pediatrics 2002;110:534-9.
90. van Wassenaer AG, Westera J, Houtzager BA, Kok JH. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial. Pediatrics 2005;116:e613-8.
91. van Wassenaer-Leemhuis A, Ares S, Golombek S, Kok J, Paneth N, Kase J, et al. Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. Thyroid 2014;24:1162-9.